| Name | Title | Contact Details |
|---|
Cytomation is a Fort Collins, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Columbia Laboratories is a specialty pharmaceutical company that develops and commercializes innovative products for women’s healthcare and endocrine-related conditions. Our FDA-approved products include formulations that treat infertility, menstrual irregularities and hormonal deficiencies. Columbia’s products utilize our proprietary Bioadhesive Delivery System (BDS), which leverages the principle of bioadhesion to administer medication. This technology can deliver many types of compounds, including hormones and peptides, providing numerous internal and licensing product development opportunities.
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team`s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
t+ Clinical is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.